| scholarly article | Q13442814 |
| P2093 | author name string | C J A Punt | |
| J H J M van Krieken | |||
| T J M Ruers | |||
| F A Vlems | |||
| G N P van Muijen | |||
| I M H A Cornelissen | |||
| J H S Diepstra | |||
| M J L Ligtenberg | |||
| Th Wobbes | |||
| P2860 | cites work | The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas | Q24312239 |
| Access to a messenger RNA sequence or its protein product is not limited by tissue or species specificity | Q28256594 | ||
| Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. | Q30469042 | ||
| Molecular detection of minimal residual disease in colorectal and breast cancer | Q33609814 | ||
| Immunocytochemical and molecular strategies for the detection of micrometastases in patients with solid epithelial tumours: a review. | Q33611348 | ||
| Detection and clinical importance of micrometastatic disease | Q33678970 | ||
| Molecular detection of micrometastases and circulating tumor cells in solid tumors. | Q33726259 | ||
| Illegitimate transcription: transcription of any gene in any cell type | Q33849869 | ||
| Molecular assays for the diagnosis of minimal residual head-and-neck cancer: methods, reliability, pitfalls, and solutions | Q34070334 | ||
| Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies | Q35831412 | ||
| Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro | Q36115108 | ||
| Cytokeratin 20 mRNA in peripheral venous blood of colorectal carcinoma patients | Q36292406 | ||
| Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR | Q36617708 | ||
| Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients | Q36619385 | ||
| Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes | Q38273567 | ||
| Sensitive detection of squamous cells in bone marrow and blood of head and neck cancer patients by E48 reverse transcriptase-polymerase chain reaction. | Q39118044 | ||
| The use of prognostic markers in surgery for colorectal cancer | Q40423747 | ||
| Prognostic value of pathological characteristics of colorectal cancer | Q40423766 | ||
| The molecular detection of circulating tumour cells | Q40462686 | ||
| The detection of minimal numbers of contaminating epithelial tumor cells in blood or bone marrow: use, limitations and future of RNA-based methods | Q40825747 | ||
| Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: a quality-assurance initiative of the EORTC melanoma cooperative group | Q40845764 | ||
| Detection of micrometastases in colorectal cancer patients by K19 and K20 reverse-transcription polymerase chain reaction. | Q40925947 | ||
| Detection of disseminated urothelial cancer cells in peripheral venous blood by a cytokeratin 20-specific nested reverse transcriptase-polymerase chain reaction | Q40931779 | ||
| Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction | Q40997423 | ||
| Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood | Q41007091 | ||
| Quality management and influential factors for the detection of single metastatic cancer cells by reverse transcriptase polymerase chain reaction. | Q41475386 | ||
| Characterization of cytokeratin 20 expression in pancreatic and colorectal cancer | Q41698518 | ||
| Fundamentals of quality assessment of molecular amplification methods in clinical diagnostics. International Federation of Clinical Chemistry Scientific Division Committee on Molecular Biology Techniques | Q41742317 | ||
| Haematogenous cytokeratin 20 mRNA as a predictive marker for recurrence in oral cancer patients | Q41891490 | ||
| Molecular cytogenetic analysis of cytokeratin 20-labeled cells in primary tumors and bone marrow aspirates from colorectal carcinoma patients | Q46426442 | ||
| Micrometastases and Survival in Stage II Colorectal Cancer | Q47805660 | ||
| Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20 | Q47916071 | ||
| Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas | Q54018330 | ||
| Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients | Q67542458 | ||
| Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significance | Q67657717 | ||
| Prognostic factors in colorectal cancer | Q68233846 | ||
| Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma | Q71020823 | ||
| Reverse transcription/polymerase chain reaction (RT/PCR) amplification of very small numbers of transcripts: the risk in misinterpreting negative results | Q71199893 | ||
| The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of disease | Q71513553 | ||
| Primers are decisive for sensitivity of PCR | Q72769719 | ||
| Expression of cytokeratin 20 in the blood of patients with disseminated carcinoma of the pancreas, colon, stomach, and lung | Q73254735 | ||
| Perioperative quantitative analysis of cytokeratin 20 mRNA in peripheral venous blood of patients with colorectal adenocarcinoma | Q73442006 | ||
| Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow | Q73494847 | ||
| Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease | Q73554833 | ||
| Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR | Q73555133 | ||
| Genetic detection of colorectal cancer cells in circulation and lymph nodes | Q73898046 | ||
| Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease-free survival | Q73936784 | ||
| Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cells | Q74067206 | ||
| Dissemination of tumor cells in patients undergoing surgery for colorectal cancer | Q74360845 | ||
| Evaluation and interest in new molecular markers in colon cancer | Q77402565 | ||
| Molecular assessment of tumour stage and disease recurrence using PCR-based assays | Q77475362 | ||
| CK20 gene expression: technical limits for the detection of circulating tumor cells | Q78199665 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 156-163 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | Journal of Clinical Pathology | Q6294965 |
| P1476 | title | Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue | |
| P478 | volume | 55 |
| Q36190607 | Association of VCAM-1 overexpression with oncogenesis, tumor angiogenesis and metastasis of gastric carcinoma |
| Q42746766 | Carcinoembryonic antigen and cytokeratin 20 in peritoneal cells of cancer patients: are we aware of what we are detecting by mRNA examination? |
| Q47908227 | Classification of Dukes' B and C colorectal cancers using expression arrays |
| Q37614696 | Clinical relevance associated to the analysis of circulating tumour cells in patients with solid tumours |
| Q50918028 | Clinical significance of survivin and VEGF mRNA detection in the cell fraction of the peripheral blood in non-small cell lung cancer patients before and after surgery |
| Q36104060 | Colon cancer: prevalence, screening, gene expression and mutation, and risk factors and assessment |
| Q54697051 | Combined use of positive and negative immunomagnetic isolation followed by real-time RT-PCR for detection of the circulating tumor cells in patients with colorectal cancers. |
| Q90427591 | Common molecular markers between circulating tumor cells and blood exosomes in colorectal cancer: a systematic and analytical review |
| Q35790044 | Critical evaluation of real-time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients |
| Q44603719 | Cytokeratin 20 and guanylyl cyclase C mRNA is largely present in lymph node and liver specimens of colorectal cancer patients |
| Q40769679 | Cytokeratin 20 positive cells in blood of colorectal cancer patients as an unfavorable prognostic marker. |
| Q54434780 | Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker |
| Q40392616 | Detection of cytokeratin 20 mRNA in the peripheral blood of patients with colorectal cancer by immunomagnetic bead enrichment and real-time reverse transcriptase-polymeras chain reaction |
| Q40619994 | Detection of disseminated tumor cells in nude mice with human gastric cancer |
| Q36154564 | Detection of disseminated tumor cells in peripheral blood |
| Q80213137 | Detection of disseminated tumor cells in the lymph nodes of colorectal cancer patients using a real-time polymerase chain reaction assay |
| Q54648079 | Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis. |
| Q41824145 | Evaluation of laparoscopic resection of colorectal carcinoma from the viewpoint of molecular biology. |
| Q38450906 | Identification of occult tumor cells in node negative lymph nodes of colorectal cancer patients by cytokeratin 20 gene and protein expression |
| Q27002450 | Molecular biomarkers for the detection of metastatic colorectal cancer cells |
| Q54599148 | Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis. |
| Q34428780 | Multiplex RT-PCR-based detections of CEA, CK20 and EGFR in colorectal cancer patients |
| Q35116516 | Nodal staging of colorectal carcinomas and sentinel nodes |
| Q88790384 | Nucleic acid quantification and disease outcome prediction in colorectal cancer |
| Q34657862 | Quantitative real-time RT-PCR detection for CEA, CK20 and CK19 mRNA in peripheral blood of colorectal cancer patients |
| Q34723168 | Relationship between vascular invasion and microvessel density and micrometastasis |
| Q35113444 | Relevance of disseminated tumour cells in blood and bone marrow of patients with solid epithelial tumours in perspective |
| Q78881249 | Reliability of quantitative reverse-transcriptase-PCR-based detection of tumour cells in the blood between different laboratories using a standardised protocol |
| Q37801547 | Sensitivity estimates of blood-based tests for colorectal cancer detection: impact of overrepresentation of advanced stage disease |
| Q35790106 | Specific detection of cytokeratin 20-positive cells in blood of colorectal and breast cancer patients by a high sensitivity real-time reverse transcriptase-polymerase chain reaction method |
| Q33753267 | The Potential for Circulating Tumor Cells in Pancreatic Cancer Management |
Search more.